Prognostic and clinicopathologic value of ki-67 and profilin 1 immunohistochemical expression in primary pT1 urothelial bladder cancer

膀胱癌 医学 免疫组织化学 癌症 内科学 生物标志物 Ki-67 肿瘤科 病理 原位癌 肿瘤进展 生物 生物化学
作者
Meftun Çulpan,Turgay Turan,Sıdıka Şeyma Özkanli,Tülay Zenginkinet,Özgür Kazan,Taha Uçar,Gökhan Atış,Turhan Çaşkurlu,Asıf Yıldırım
出处
期刊:Journal of Cancer Research and Therapeutics [BioMed Central]
卷期号:17 (2): 434-434 被引量:4
标识
DOI:10.4103/jcrt.jcrt_408_19
摘要

To investigate the prognostic and clinicopathologic value of Ki-67 and profilin 1 immunohistochemical expression in primary pT1 papillary urothelial bladder cancer.This study included 88 male and 13 female pT1 primary bladder cancer patients. Demographic characteristics, tumor histological grade, tumor number, presence of concomitant carcinoma in situ, tumor size, and status of recurrence or progression were recorded for each patient. Expression of Ki-67 and profilin 1 was evaluated by immunohistochemical analysis of paraffin-embedded tumor tissues. The Pearson's Chi-square test was used for the analysis of qualitative data, and the Kaplan-Meier method and the log-rank test were used for the survival analysis.In the mean follow-up period of 52 months, 52 (51.5%) patients experienced recurrence, 24 (23.8%) patients experienced progression, and 17 (16.8%) patients died from bladder cancer-related causes. Ki-67 expression was significantly associated with tumor histological grade (P = 0.001). In multivariate analysis, Ki-67 positivity had significantly worse outcome for recurrence (P = 0.006) and mortality (P = 0.022). Ki-67-positive (Ki-67 index ≥15%) patients had shorter recurrence-free (P = 0.003), progression-free (P = 0.002), and cancer-specific (P = 0.003) survival. However, no statistically significant relationship was found between profilin 1 expression and clinicopathologic features and prognosis.Ki-67 is a highly predictive biomarker for recurrence-free, progression-free, and cancer-specific survival in pT1 bladder cancer patients, in whom prediction of recurrence and progression are difficult. Ki-67 expression can be safely combined with other prognostic factors. However, in pT1 bladder cancer patients, no significant relationship was found between profilin 1 expression and tumor characteristics or prognostic parameters.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
idiot完成签到,获得积分10
1秒前
ff12456完成签到,获得积分10
2秒前
哎哟喂完成签到,获得积分10
2秒前
xue发布了新的文献求助10
3秒前
无聊的谷南完成签到,获得积分10
4秒前
罗氏集团完成签到,获得积分10
4秒前
lkkkkk完成签到,获得积分10
5秒前
8秒前
木槿完成签到 ,获得积分10
9秒前
天真玲完成签到,获得积分10
10秒前
小小的梦想完成签到,获得积分10
10秒前
媛子赚大qian完成签到,获得积分10
10秒前
zzzz完成签到 ,获得积分10
11秒前
高高的夕阳完成签到,获得积分10
12秒前
wuhao完成签到 ,获得积分10
12秒前
mmy完成签到 ,获得积分10
13秒前
Zhang完成签到,获得积分10
14秒前
SY完成签到,获得积分10
15秒前
KKK完成签到,获得积分10
15秒前
魏小哞发布了新的文献求助10
15秒前
大模型的应助被小蓝采纳,获得10
16秒前
Tardigrade完成签到,获得积分10
16秒前
CAOHOU的应助被科研通管家采纳,获得10
17秒前
syvshc的应助被科研通管家采纳,获得10
17秒前
17秒前
酷波er的应助被科研通管家采纳,获得10
17秒前
丘比特的应助被科研通管家采纳,获得10
17秒前
sagitar的应助被科研通管家采纳,获得20
17秒前
17秒前
17秒前
cdercder的应助被科研通管家采纳,获得10
18秒前
CAOHOU的应助被科研通管家采纳,获得10
18秒前
18秒前
18秒前
66完成签到,获得积分10
18秒前
xxxxx完成签到,获得积分10
18秒前
呆萌芙蓉完成签到 ,获得积分10
18秒前
完美青旋完成签到,获得积分10
20秒前
20秒前
彩卷卷完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185571
求助须知:如何正确求助?哪些是违规求助? 9574325
关于积分的说明 21835086
捐赠科研通 7783326
什么是DOI,文献DOI怎么找? 3434597
关于科研通互助平台的介绍 2558985
邀请新用户注册赠送积分活动 2481372